Inflammatory immune cells predict survival and relapse in multiple myeloma

A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell atlas, which includes robust patient outcome data, provides unparalleled new insights into how the immune system interacts with cancerous plasma cells and can be used to determine how aggressive a patient’s multiple myeloma is likely to be.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup